Competition office fines Phytotec on misleading advertising charges
Hungaryʼs Competition Office (GVH) today said it had fined Phytotec Hungária Kereskedelmi és Szolgáltató close to HUF 2 mln on charges of misleading advertising, Hungarian news agency MTI reported.
GVH said the company provided false information regarding the ingredients of its OTC medicine Esberitox and failed to label the product according to licensed instructions for use and this was shown in its product advertisements for almost a year.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.